Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04100668 · ClinicalTrials.gov registry record · NA
Evaluation of Sensifree's Alpha Sensor Signal Morphology Compared to Arterial Line and PPG Signal Morphologies
A NA study, sponsored by Sensifree.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04100668: Completed NA study, sponsored by Sensifree.
NCT04100668 is a NA study that has completed, run by Sensifree. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04100668, a NA study, has completed, sponsored by Sensifree.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of the protocol is to compare Sensifree Alpha sensor signal morphology, measured at the radial artery, to an invasive arterial line pressure signal and the oxygen saturation as read by a pulse oximeter. The study will be split into two phases: the first phase will collect data for morphology analysis and algorithm development, the second phase will compare device performance to the reference invasive blood pressures. A secondary objective is to evaluate signal morphology changes due to changes in subject arm position.
Primary Outcome
BP waveform will be acquired form three sources (PPG, A-line and investigational device),data will be statistically analyzed to find the correlations between the different sources of BP waveform
Interventions
- DEVICE GE Datex-Ohmeda Oxy-F Finger Clip Pulse Oximeter Sensor
- DEVICE Arrow® arterial catheterization kit (Teleflex)
- DEVICE Sensifree's Alpha sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-09-26 |
| Est. Completion | 2017-09-29 |
| Phase | NA |
What the finished NCT04100668 record still lists
NCT04100668 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which GE Datex-Ohmeda Oxy-F Finger Clip Pulse Oximeter Sensor is the first listed.
NCT04100668 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04100668 about?
NCT04100668 is a clinical study titled "Evaluation of Sensifree's Alpha Sensor Signal Morphology Compared to Arterial Line and PPG Signal Morphologies". The purpose of the protocol is to compare Sensifree Alpha sensor signal morphology, measured at the radial artery, to an invasive arterial line pressure signal and the oxygen saturation as read by a pulse oximeter. The study will be split into two phases: the first phase will collect data for morph...
What is the current status of trial NCT04100668?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2017-09-26. Estimated completion is 2017-09-29.
What interventions are being tested in trial NCT04100668?
The interventions under investigation include: GE Datex-Ohmeda Oxy-F Finger Clip Pulse Oximeter Sensor (DEVICE), Arrow® arterial catheterization kit (Teleflex) (DEVICE), Sensifree's Alpha sensor (DEVICE).
Who is sponsoring clinical trial NCT04100668?
This trial is sponsored by Sensifree, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04100668's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI